• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Empagliflozin

Empagliflozin

Product ID E499601
Cas No. 864070-44-0
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $56.70 In stock
10 mg $78.80 In stock
50 mg $210.00 In stock
100 mg $341.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Empagliflozin is a sodium glucose cotransporter 2 inhibitor. Chronic treatment of Zucker diabetic fatty rats with empagliflozin was able to prevent the development of oxidative stress, AGE/RAGE signaling and inflammation, and to partially improve endothelial function. High-dose treatment of C57BL/6J mice with empagliflozin resulted in suppressed weight gain in addition to ameliorating glucose intolerance and insulin resistance. Empagliflozin treatment also protected mice from diet-induced hepatic steatosis and inflammation, decreased M1 macrophages, and increased M2 macrophages. Additionally, empagliflozin treatment lowered blood glucose levels, improved cardiac function, improved histopathalogic changes in the myocardium, and inhibited cardiomyocyte apoptosis by down-regulating expression of CHOP and GRP8 and inactivating caspase-12 in diabetic cardiomyopathy rats.

Product Info

Cas No.

864070-44-0

Purity

≥98%

Formula

C23H27ClO7

Formula Wt.

450.91

Chemical Name

(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

IUPAC Name

(1S)-1,5-Anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol

Synonym

Jardiance

Solubility

30mg/mL in organic solvents such as ethanol, DMSO, and dimethyl formamide. Sparingly soluble in aqueous buffers.

Shipping and Storage

Store Temp

-20°C

Ship Temp

Blue Ice

Downloads

MSDS

E499601 MSDS PDF

Info Sheet

E499601 Info Sheet PDF

References

Steven S, Oelze M, Hanf A, et al. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biol. 2017 Oct;13:370-385. PMID: 28667906.

Xu L, Nagata N, Nagashimada M, et al. SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice. EBioMedicine. 2017 Jun;20:137-149. PMID: 28579299.

Zhou Y, Wu W. The sodium-glucose co-transporter 2 inhibitor, empagliflozin, protects against diabetic cardiomyopathy by inhibition of the endoplasmic reticulum stress pathway. Cell Physiol Biochem. 2017;41(6):2503-2512. PMID: 28472796.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E6783

    R-Equol

    Isoflavone, phytoestrogen found in soy

    ≥98%
  • A464768

    Altertoxin 1

    Mycotoxin contaminant in food and feed.

    ≥97%
  • C1637

    Ceftriaxone Disodium Hemiheptahydrate

    β-lactam cephalosporin; penicillin binding pro...

    ≥98%
  • L2800

    LH846

    Casein kinase 1α/δ/ε inhibitor.

    ≥98%
  • C0251

    Calcitonin Gene Related Peptide II, rat

    Calcitonin-family peptide, involved in vasodila...

    ≥95%
  • S164098

    Seco-rapamycin

    Rapamycin analog

    ≥73%
  • F285081

    Fidaxomicin

    Macrocycle

    ≥98%
  • V174459

    Velpatasvir

    Inhibits NS5A

    ≥99%
  • E5220

    Enfuvirtide (T-20)

    Synthetic peptide derived from HIV-1; viral fus...

    ≥95%
  • T0090

    7-(Triethylsilyl)-baccatin III

    Synthetic taxol synthesis intermediate; microtu...

    ≥98%
  • F8270

    Furosemide

    Loop diuretic; NKCC symporter inhibitor, CFTR C...

    ≥97%
  • A016493

    4-Aminopyrimidine

    Building block

    ≥98%
  • E4785

    Elvitegravir

    Integrase inhibitor.

    ≥98%
  • A5234

    Amisulpride

    5-HT7 and D2/3 antagonist.

    ≥98%
  • P6264

    PPQ-102

    Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...

    ≥98%
  • M1669

    6-Mercaptopurine Monohydrate

    Thiopurine antimetabolite; PRPP amidotransferas...

    ≥98%
  • C0255

    Cantharidin

    Toxin produced by Canarthis vesicatoria; PP1/2A...

    ≥98%
  • E5569

    Enramycin B

    Polypeptide; peptidoglycan inhibitor.

    ≥83%
  • W0275

    R-(+)-Warfarin Sodium >99%ee

    Coumarin; VKORC1 inhibitor.

    ≥99%
  • M3353

    Minocycline Hydrochloride

    Tetracycline; protein translation inhibitor, MM...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only